SCHEMBL6988282

SCHEMBL6988282

CC1OCC(=O)C1(C)NC(=O)C(CNC(=O)c1ccc(OC(F)(F)F)cc1)c1cccc(O)c1

nearest known ligand 0.41

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 18/20 0.41
GPR139 Q6DWJ6 1/20 0.36
CTSL P07711 1/20 0.36
CTSS P25774 1/20 0.36
CTSK P43235 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6990344 0.90 MEN1 (0.37) TRPV1GPR139CTSL
SCHEMBL6981853 0.90 TRPV1 (0.42) TRPV1
SCHEMBL6989479 0.90 ATM (0.39)
SCHEMBL6987228 0.88 CTSK (0.37) CTSLCTSK
SCHEMBL6985507 0.88 SMN1; SMN2 (0.37) GPR139CTSLCTSK
SCHEMBL6988090 0.87 TP53 (0.35)
SCHEMBL6986649 0.85 HTR1A (0.40) CTSK
SCHEMBL6991034 0.85 TAS1R3 (0.34)
SCHEMBL6749648 0.83 TRPV1 (0.45) TRPV1CTSLCTSSCTSK
SCHEMBL6990359 0.83 HPGD (0.38) CTSLCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1362042-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES Amura Therapeutics Limited (GB) 2003-11-19 EP disclosed
WO-2002057249-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES AMURA THERAPEUTICS LIMITED (GB) 2002-07-25 WO disclosed